MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Can we afford the cancer care of the future?

Back to cancer blog Blogs list Cancer blog  


Subscribe To Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Can we afford the cancer care of the future?




When a cancer patient and his or her doctor discuss the value of a therapy option, the conversation commonly centers on a consideration of the therapy's medical benefits versus its possible side effects for the patient. Increasingly, however, as the already high costs of cancer care continue to rise, a full view of the patient's welfare must also take into account the economic impact of the therapy on the patient and his or her family.

Additionally, beyond its clear impact on patients, the increasing cost of cancer care also presents challenges to other stakeholders involved in the development and delivery of care.



Can we afford the cancer care of the future?

"Cancer care is one of the most expensive areas of health care today, and the cost of that care is increasing steadily, for patients and for society as a whole," says Neal J. Meropol, M.D., director of the gastrointestinal cancer and gastrointestinal tumor risk evaluation programs at Fox Chase Cancer Center. Meropol, who is also a member of the American Society of Clinical Oncology (ASCO) Cost of Care Task Force and main author on the upcoming ASCO Guidance Statement on the Cost of Cancer Care, offered his analysis of the problem in a talk presented at the ASCO annual meeting in Orlando today.

"As physicians, we have a responsibility to understand the impact that the increasing cost of cancer care has on everyone involved," Meropol notes. "In particular, we need to be able to discuss with our patients the impact that high out-of-pocket expenses might have on them and their families, however difficult that conversation might be. More and more, cost considerations have an appropriate role in the evaluation of therapy options".

As per Meropol, other stakeholders affected by the rising cost of cancer care in addition to patients include employers who must remain competitive while subsidizing their employees' health care, health insurance providers who must watch their bottom lines while deciding which therapys to pay for and at what level, physicians who must offer guidance for their patients in choosing among therapys, including new drugs that might offer modest survival benefits but at significant additional cost, and the pharmaceutical industry, which hopes to earn a profit from the sale of innovative drugs that can cost $1 billion to research and develop.

Meropol observes that a number of of the costly new cancer drugs now coming to market are highly targeted in their action, often quite effective but only in a subset of patients. While these drugs anticipate the dream of personalized medicine, their high costs must be shared over a smaller potential pool of patients, perhaps threatening the future of this promising new direction in medicine.

Rising costs also have the potential to widen the disparities that already exist in cancer outcomes among different populations, adding an ethical dimension to the problem.

"Rising costs appears to be a key impediment to reaching our societal goal of providing high quality cancer care to all citizens," Meropol says.

Going forward, the challenges in confronting the cost-of-cancer-care issue are substantial. Patients and their physicians both feel ill-equipped to consider therapy costs in the clinical setting, and society has yet to address this multifaceted issue in a comprehensive way. Still, Meropol says, we have no alternative but to begin the search for answers now. The increasing economic burden posed by cancer-care costs on patients and their families and on society is too great to ignore.


Posted by: Janet    Source




Did you know?
When a cancer patient and his or her doctor discuss the value of a therapy option, the conversation commonly centers on a consideration of the therapy's medical benefits versus its possible side effects for the patient. Increasingly, however, as the already high costs of cancer care continue to rise, a full view of the patient's welfare must also take into account the economic impact of the therapy on the patient and his or her family.

Medicineworld.org: Can we afford the cancer care of the future?

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.